The Merck Access Program for RENFLEXIS® (infliximab-abda)
Before prescribing RENFLEXIS, please read the accompanying Prescribing Information including the Boxed Warning about serious infections and malignancies. The Medication Guide also is available.

New Q-code available April 1, 2018.

Please click here for additional information.

WELCOME TO

THE MERCK ACCESS PROGRAM

ARE YOU A US HEALTH CARE PROFESSIONAL?
YES
NO

THE MERCK ACCESS PROGRAM FOR RENFLEXIS

May be able to answer questions about:
  • Benefit investigations
  • Prior authorizations and appeals
  • Co-pay assistance for eligible patients
  • Referral to the Merck Patient Assistance Program for eligibility determination (provided through the Merck Patient Assistance Program, Inc.)
  • Billing and coding